Effectiviness of a Brief Intervention on anti-smoking motivation in drug addict patients staying in a UHD
Abstract
Justification: There is a connection between smoking and substances use disorder, especially alcohol and cannabis. Nevertheless, health interventions seem not to be addressed to this approach.
Objective: Evaluation of the motivation degree for the smoking quit after developing a brief psycho-educational intervention on smoking.
Methodology: It is a quantitative research of analytical type, almost experimental, developed by means of two experimental series, of the types pre- and post- intervention. A brief educational intervention is applied and there is an evaluation of the differences in the motivation for the smoking quit in a group before the intervention and in another one after the intervention.
Results: There is a difference of 1,27 points in the degree of motivation found in the individuals regarding the experimental groups.
Conclusions: Drug addict people are smokers with a high degree of nicotinic dependence, so it is necessary to design suitable strategies of quitting. .
Downloads
References
Beck AK, Baker AL, Todd J. Smoking in schizophrenia: Cognitive impact of nicotine and relationship to smoking motivators. Schizophr Res Cogn. 2015;2(1):26–32.
Lasser, K; Boyd, JW; Woolhandler, S; Himmelstein, DU; McCormick, D; Bor, DH. Smoking and mental illness—a population-based prevalence study. Journal of the American Medical Association 2000; 284:2606–2610.
Anderson GD, Chan LN. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products. Vol. 55, Clinical Pharmacokinetics. 2016. p. 1353–68.
Degenhardt, L; Hall, W; Lynskey, M. The relationship between cannabis use and other substance use in the general population. Drug and Alcohol Dependence 2001; 64:319-327.
Rodeiro SV. Influencia de la presencia de patología psiquiátrica en la cesación tabáquica Estudio de los pacientes tratados. Universidad de Cantabria; 2016.
Hurt, RD; Offord, KP; Croghan, IT; GomezDahl, LC; Kottke, TE; Morse, RM; et al. Mortality following inpatient addiction treatment: Role of tobacco use in a communibased cohort. Journal of the American Medical Association 1996; 275:1097-1103.
Williams JM, Miskimen T, Minsky S, Cooperman NA, Miller M, Budsock PD, et al. Increasing Tobacco Dependence Treatment Through Continuing Education Training for Behavioral Health Professionals. Psychiatr Serv. 2015;66(1):21–6.
Keizer I, Gex-Fabry M, Bruegger A, Croquette P, Khan AN. Staff representations and tobacco-related practices in a psychiatric hospital with an indoor smoking ban. Int J Ment Health Nurs. 2014;23(2):171–82.
Friend, KB; Pagano, ME. Smoking cessation and alcohol consumption in individuals in treatment for alcohol use disorders. Journal of Addictive Disseases Impact & Description 2005; 24:61-75.
Friend, KB; Pagano, ME. Changes in cigarette consumption and drinking outcomes: findings from Proyect MATCH. Journal of Substance Abuse Treatment 2005; 29:221-229.
Grup de Treball de tabac i Salut Mental. Xarxa Catalana d´Hospitals sense fum. Guía d´Intervenció Clínica en el consum de tabac en pacients amb trastorn mental. Barcelona; 2012.
Shmueli, D; Fletcher, L; Hall, SE; Hall, SM; Prochaska, JJ. Changes in psychiatric patients´ thoughts about quitting smoking during a smoke-free hospitalization. Nicotine & Tobacco Research 2008; 10:875-881.
Ballbe M, Sureda X, Martinez-Sanchez JM, Fu M, Salto E, Gual a., et al. Secondhand smoke in psychiatric units: patient and staff misperceptions. Bmj. 2014;1–9.
Marques de Oliveira, R; Ferreira Furegato, AR. Esquizofrenia y dependencia del tabaco: una revisión integradora. Revista electrónica Enfermería Global Enero 2012; 25:381-403.
Sheals K, Tombor I, McNeill A, Shahab L. A mixed-method systematic review and meta-analysis of mental health professionals’ attitudes toward smoking and smoking cessation amongst people with mental illnesses. Addiction. 2016;1536–53.
Fagerström KO. Measuring degrees of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3:235-41
Richmond RL. Multivariate models for predicting abstention following intervention to stop smoking by general practitioners. Addiction 1993; 88: 1127-35.
Hall, SM; Tsoh, JY; Prochaska, JJ; Eisendrath, S; Rossi, JS; et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. American Journal of Public Health 2006; 96:1808–1814.
Prochaska, JJ; Fletcher, L; Hall, SE; Hall, SM. Return to smoking following a smoke-free psychiatric hospitalization. American Journal on Addictions 2006;15:15–22.
De León, J; Díaz, FJ. A meta-analysis of world studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research 2005; 76:135-157.
Lira-Mandujano, J; González-Betanzos, F; Carrascoza Venegas, CA; Ayala, HE; Cruz-Morales, S. Evaluación de un programa de intervención breve motivacional para fumadores: resultados de un estudio piloto. Salud Mental 2009; 32:35-41.
Dunn, C; Deroo, L; Rivara, FP. The use of brief adapted from motivational interviewing across behavioral domains: A systematic review. Addiction 2001; 96:1725-1742.
Piñeiro, B; Miguez, MC; Becoña, E. La entrevista motivacional en el tratamiento del tabaquismo: una revisión. Adicciones 2010; 22(4):353-364.
Barrueco Ferrero, M; Jiménez Ruiz, C; Palomo Cobos, L; Torrecilla García, M; Romero Palacios, P; Riesco Miranda, JA. Abstinencia puntual y continuada con el tratamiento farmacológico del tabaquismo en la práctica clínica. Medicina Clínica 2004;123(17):652-56.
McRobbie H, Thornley S, Bullen C, Lin R-B, Senior H, Laugesen M, et al. A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction. Addiction. 2010;105(7):1290–8.
Anthenelli R, Benowitz N, West R, Aubin L, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet (London, England). 2016;387:2507–20.
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.
